Dostinex
On April 25, 2007, the FDA ordered the stopping of all U.S. sales of the prescription drug Dostinex. This order was issued after the New England Journal of Medicine published a study concluding that Dostinex can cause one's heart valve to overgrow, weaken and/or become leaky or fail. In almost all cases the individual must undergo open heart surgery to repair the problem. Dostinex is the publicly traded name for the drug cabergoline. This drug is made from a fungus called or known as Ergot. These drugs are used for the condition of Parkinsons and restless leg syndrome and in some cases migraines. Dostinex is prescribed for hyperprolactinemic disorder and related hormonal conditions, and is used to reduce or prevent the production of breast milk. It should be noted that Dostinex was never approved for treatment of Parkinson's in the United States Market. It is also important to note that the studies that tanked Dostinex showed that at least 14 patients have needed heart valve replacements to date.
If you or a loved one have taken DOSTINEX and have now been diagnosed with a heart value issue or a leaky valve - call our Law Firm as soon as possible at 1-800-862-1260. 
